243 related articles for article (PubMed ID: 29778097)
21. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.
Kinon BJ; Gilmore JA; Liu H; Halbreich UM
Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():55-68. PubMed ID: 12650681
[TBL] [Abstract][Full Text] [Related]
22. Hyperprolactinemia associated with psychotropics--a review.
Madhusoodanan S; Parida S; Jimenez C
Hum Psychopharmacol; 2010; 25(4):281-97. PubMed ID: 20521318
[TBL] [Abstract][Full Text] [Related]
23. Mutant prolactin receptor and familial hyperprolactinemia.
Newey PJ; Gorvin CM; Cleland SJ; Willberg CB; Bridge M; Azharuddin M; Drummond RS; van der Merwe PA; Klenerman P; Bountra C; Thakker RV
N Engl J Med; 2013 Nov; 369(21):2012-2020. PubMed ID: 24195502
[TBL] [Abstract][Full Text] [Related]
24. [Prolactin, antipsychotics and breast cancer: is there a connection?].
Sabbe T; Detraux J; De Hert M
Tijdschr Psychiatr; 2016; 58(9):641-9. PubMed ID: 27639886
[TBL] [Abstract][Full Text] [Related]
25. Risk of hyperprolactinemia and sexual side effects in males 10-20 years old diagnosed with autism spectrum disorders or disruptive behavior disorder and treated with risperidone.
Roke Y; Buitelaar JK; Boot AM; Tenback D; van Harten PN
J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):432-9. PubMed ID: 23234586
[TBL] [Abstract][Full Text] [Related]
26. [Hyperprolactinemia in mentally ill patients].
Carvalho MM; Góis C
Acta Med Port; 2011; 24(6):1005-12. PubMed ID: 22713195
[TBL] [Abstract][Full Text] [Related]
27. Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition.
Sultan AS; Brim H; Sherif ZA
Cancer Sci; 2008 Feb; 99(2):272-9. PubMed ID: 18271926
[TBL] [Abstract][Full Text] [Related]
28. Prolactin and macroprolactin levels in psychiatric patients receiving atypical antipsychotics: A preliminary study.
Park YM; Lee SH; Lee BH; Lee KY; Lee KS; Kang SG; Lee HY; Kim W
Psychiatry Res; 2016 May; 239():184-9. PubMed ID: 27010188
[TBL] [Abstract][Full Text] [Related]
29. Hyperprolactinemia in psychotic patients treated in monotherapy with long-acting injectable antipsychotics.
Bonete Llácer JM; Martínez Hortelano A; Richart Albelda B
Int J Psychiatry Clin Pract; 2019 Sep; 23(3):189-193. PubMed ID: 30848967
[No Abstract] [Full Text] [Related]
30. Characteristics and Management of Granulomatous Lobular Mastitis Associated with Antipsychotics-Induced Hyperprolactinemia.
Tian C; Wang H; Liu Z; Han X; Ning P
Breastfeed Med; 2022 Jul; 17(7):599-604. PubMed ID: 35447036
[No Abstract] [Full Text] [Related]
31. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
Arakawa R; Okumura M; Ito H; Takano A; Takahashi H; Takano H; Maeda J; Okubo Y; Suhara T
J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897
[TBL] [Abstract][Full Text] [Related]
32. Add-on effects of a low-dose aripiprazole in resolving hyperprolactinemia induced by risperidone or paliperidone.
Qiao Y; Yang F; Li C; Guo Q; Wen H; Zhu S; Ouyang Q; Shen W; Sheng J
Psychiatry Res; 2016 Mar; 237():83-9. PubMed ID: 26921057
[TBL] [Abstract][Full Text] [Related]
33. Rankl Impairs Lactogenic Differentiation Through Inhibition of the Prolactin/Stat5 Pathway at Midgestation.
Cordero A; Pellegrini P; Sanz-Moreno A; Trinidad EM; Serra-Musach J; Deshpande C; Dougall WC; Pujana MA; González-Suárez E
Stem Cells; 2016 Apr; 34(4):1027-39. PubMed ID: 26695351
[TBL] [Abstract][Full Text] [Related]
34. Significant elevations of prolactin levels in patients who shifted from conventional depot antipsychotics to long-acting risperidone.
Lai YC; Chiou CC; Chen CH; Huang MC
J Clin Psychopharmacol; 2007 Oct; 27(5):523-4. PubMed ID: 17873693
[No Abstract] [Full Text] [Related]
35. The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma.
Keller A; Wingelhofer B; Peter B; Bauer K; Berger D; Gamperl S; Reifinger M; Cerny-Reiterer S; Moriggl R; Willmann M; Valent P; Hadzijusufovic E
Vet Comp Oncol; 2018 Mar; 16(1):55-68. PubMed ID: 28397975
[TBL] [Abstract][Full Text] [Related]
36. Association between long-term use of prolactin-elevating antipsychotics in women and the risk of breast cancer: What are the clinical implications?
Hope JD; Keks NA; Copolov DL
Australas Psychiatry; 2023 Apr; 31(2):205-208. PubMed ID: 36927059
[TBL] [Abstract][Full Text] [Related]
37. Lactogens protect rodent and human beta cells against glucolipotoxicity-induced cell death through Janus kinase-2 (JAK2)/signal transducer and activator of transcription-5 (STAT5) signalling.
Kondegowda NG; Mozar A; Chin C; Otero A; Garcia-Ocaña A; Vasavada RC
Diabetologia; 2012 Jun; 55(6):1721-32. PubMed ID: 22382519
[TBL] [Abstract][Full Text] [Related]
38. Prolactin signal transduction mechanisms in the mammary gland: the role of the Jak/Stat pathway.
Watson CJ; Burdon TG
Rev Reprod; 1996 Jan; 1(1):1-5. PubMed ID: 9414431
[TBL] [Abstract][Full Text] [Related]
39. Antipsychotic-induced hyperprolactinemia.
Bostwick JR; Guthrie SK; Ellingrod VL
Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
[TBL] [Abstract][Full Text] [Related]
40. Frequency of hyperprolactinemia and its associations with demographic and clinical characteristics and antipsychotic medications in psychiatric inpatients in China.
Wang ZM; Xiang YT; An FR; Correll CU; Ungvari GS; Wang CY; Lai KY; Bo QJ; Li Y; Zhong BL; Chiu HF
Perspect Psychiatr Care; 2014 Oct; 50(4):257-63. PubMed ID: 24256051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
